ArticleBMC microbiology2025
Genomic and functional analyses reveal Pseudomonas granadensis CT364 is a plant growth-promoting endophyte.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rhizoxin and 2,4-diacetylphloroglucinol contribute to biocontrol ofMicrobiology spectrum · 2026Article
- Whole-genome sequencing and characterization ofFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPlant-associated endophytes offer promising agricultural, environmental, and biotechnological applications. Despite their potential utility, difficulties in culturing these microorganisms under laboratory conditions have limited both their isolation and a comprehensive understanding of their biology, function, and ecological role. Against this background, Pseudomonas granadensis strain CT364-isolated from the olive tree rhizosphere-emerged as a potential endophyte of interest due to its cultivability and its ability to promote rooting across diverse species, including olive trees, rapeseed, mung bean and cowpea.
resultsGenome Annotation and in silico predictions identified 564 genes linked to rhizosphere competence, plant colonisation and plant growth-promoting traits. Experimental findings confirmed the strain's motility, capacity for biofilm formation, and ability to sense and respond to plant-derived signals. P. granadensis CT364 effectively colonises the rhizosphere, rhizoplane, and internal tissues of Arabidopsis, confirming its endophytic nature without exhibiting any pathogenic traits. Inoculation experiments demonstrated significant effects on root architecture and increases in plant biomass and rosette area. Notably, these benefits were retained under salinity and osmotic stress, underscoring its plant growth-promoting ability. Finally, both genome analysis and experimental tests confirmed its resistance to osmotic stress and heavy metal toxicity, highlighting the strain's ability to survive in difficult environments.
conclusionsThe integration of genomic insights and experimental validation supports the conclusion that P. granadensis CT364 is a plant growth-promoting endophytic bacterium. Its ability to enhance plant development under both optimal and stressful conditions, combined with its ability to colonise Arabidopsis and non-pathogenic nature, positions this strain as a potential bioinoculant for sustainable agriculture. Furthermore, the identification of specific genes related to plant sensing and colonisation, and its genetic tractability, open avenues for exploring underlying mechanisms of plant-microbe interactions. In summary, P. granadensis CT364 therefore not only holds potential for improving crop performance under challenging environmental conditions but also offers a valuable model for the study of beneficial plant-bacterial symbiosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.